Oliver Bissinger MD, DDS, PhD

Oliver Bissinger studied Medicine and Dentistry in Munich, Germany, and in Sydney, Australia. In 2008, he started as a resident at the Department of Oral and Maxillofacial Surgery, "Klinikum Rechts der Isar", Technical University Munich. In the context of his medical (MD) and dental (DDS) doctoral theses, he used imaging and laboratory modalities to assess bone regeneration after the application of (the genetic information) rhBMP-2 or different drugs in the rat. In 2015, he worked at the CSIRO for research in terms of scaffolds and RAFT polymerization. In the same year, he also became a specialist in oral- and maxillofacial surgery and a consultant. In 2017, he achieved the designation 'plastic operations'. In 2018, he became a fellow of the European Board of Oral-Maxillo-Facial-Surgery, Head and Neck Surgery (FEBOMFS) and finished his Ph.D. and got the 'venia legendi'. In this context, he designs teaching courses and holds lectures. His main research includes the assessment of the influence of a polymer-based therapy (RAFT polymerization) aimed at transfection and expression of BMP-2. In this context, biodegradable scaffolds are investigated in vivo (rat critical-size-defect-models) in regard to their osteogenic/antiinfective properties. Bone and blood vessels are examined simultaneously by using microCT and IHC. The role of BMP-2 is also evaluated on protein and RNA levels. In this context, he achieved a third-party-funded project of the highly reputed DFG (German Research Foundation) as an exclusive first applicant. He has published 26 peer-reviewed original papers with more than 194 citations and reached an H-index of 7.